Literature DB >> 18412193

Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4.

Shinya Oishi1, Ryo Masuda, Barry Evans, Satoshi Ueda, Yukiko Goto, Hiroaki Ohno, Akira Hirasawa, Gozoh Tsujimoto, Zixuan Wang, Stephen C Peiper, Takeshi Naito, Eiichi Kodama, Masao Matsuoka, Nobutaka Fujii.   

Abstract

The design, synthesis, and bioevaluation of fluorescence- and biotin-labeled CXCR4 antagonists are described. The modification of D-Lys8 at an epsilon-amino group in the peptide antagonist Ac-TZ14011 derived from polyphemusin II had no significant influence on the potent binding of the peptide to the CXCR4 receptor. The application of the labeled peptides in flow cytometry and confocal microscopy studies demonstrated the selectivity of their binding to the CXCR4 receptor, but not to CXCR7, which was recently reported to be another receptor for stromal cell-derived factor 1 (SDF-1)/CXCL12.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412193     DOI: 10.1002/cbic.200700761

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  17 in total

1.  The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.

Authors:  Stéphanie Gravel; Camille Malouf; Philip E Boulais; Yamina A Berchiche; Shinya Oishi; Nobutaka Fujii; Richard Leduc; Daniel Sinnett; Nikolaus Heveker
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

2.  GnRH suppresses excitability of visual processing neurons in the optic tectum.

Authors:  Chie Umatani; Ryosuke Misu; Shinya Oishi; Kazuhiko Yamaguchi; Hideki Abe; Yoshitaka Oka
Journal:  J Neurophysiol       Date:  2015-09-09       Impact factor: 2.714

Review 3.  Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.

Authors:  T R Nayak; H Hong; Y Zhang; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

4.  Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide.

Authors:  Joeri Kuil; Tessa Buckle; Hushan Yuan; Nynke S van den Berg; Shinya Oishi; Nobutaka Fujii; Lee Josephson; Fijs W B van Leeuwen
Journal:  Bioconjug Chem       Date:  2011-04-19       Impact factor: 4.774

5.  Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC.

Authors:  Nynke S van den Berg; Tessa Buckle; Joeri Kuil; Jelle Wesseling; Fijs W B van Leeuwen
Journal:  Transl Oncol       Date:  2011-08-01       Impact factor: 4.243

6.  Potent CXCR4 antagonists containing amidine type Peptide bond isosteres.

Authors:  Eriko Inokuchi; Shinya Oishi; Tatsuhiko Kubo; Hiroaki Ohno; Kazuya Shimura; Masao Matsuoka; Nobutaka Fujii
Journal:  ACS Med Chem Lett       Date:  2011-03-28       Impact factor: 4.345

7.  Mapping the ligand-binding site on a G protein-coupled receptor (GPCR) using genetically encoded photocrosslinkers.

Authors:  Amy Grunbeck; Thomas Huber; Pallavi Sachdev; Thomas P Sakmar
Journal:  Biochemistry       Date:  2011-04-07       Impact factor: 3.162

8.  Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4.

Authors:  Siyu Zhu; Qian Meng; Robert T Schooley; Jing An; Yan Xu; Ziwei Huang
Journal:  Molecules       Date:  2019-08-13       Impact factor: 4.411

9.  Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents.

Authors:  Ole Tietz; Nazila Kamaly; Graham Smith; Elham Shamsaei; Kishore K Bhakoo; Nicholas J Long; Eric O Aboagye
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-07-10

Review 10.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.